Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 1/20 | 0.66 |
| ▸ | MAOB | P27338 | 1/20 | 0.66 |
| ▸ | GAA | P10253 | 1/20 | 0.64 |
| ▸ | PTPRC | P08575 | 2/20 | 0.63 |
| ▸ | CTSL | P07711 | 1/20 | 0.63 |
| ▸ | CTSS | P25774 | 1/20 | 0.63 |
| ▸ | PTPN13 | Q12923 | 1/20 | 0.63 |
| ▸ | TDP2 | O95551 | 3/20 | 0.59 |
| ▸ | NSD2 | O96028 | 3/20 | 0.59 |
| ▸ | PAX8 | Q06710 | 3/20 | 0.59 |
| ▸ | ABL1 | P00519 | 1/20 | 0.59 |
| ▸ | PLCG1 | P19174 | 1/20 | 0.59 |
| ▸ | CES1 | P23141 | 1/20 | 0.59 |
| ▸ | RIN1 | Q13671 | 1/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | THRB | P10828 | 1/20 | 0.53 |
| ▸ | BLM | P54132 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | S100A4 | P26447 | 5/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4556066 | 0.96 | PTPRC (0.69) | MAOAMAOBGAAPTPRCCTSL | |
| SCHEMBL9672513 | 0.93 | MAOA (0.66) | MAOAMAOBGAAPTPRCCTSL | |
| SCHEMBL16352242 | 0.91 | MAOA (0.69) | MAOAMAOBGAAPTPRCCTSL | |
| SCHEMBL28663543 | 0.89 | MAOA (0.72) | MAOAMAOBGAAPTPRCCTSL | |
| SCHEMBL30799541 | 0.82 | PTPRC (0.91) | MAOAGAAPTPRCCTSLCTSS | |
| SCHEMBL69772 | 0.82 | PTPRC (0.91) | MAOAGAAPTPRCCTSLCTSS | |
| SCHEMBL29350676 | 0.80 | MAOA (1.00) | MAOAMAOBGAAPTPRCCTSL | |
| SCHEMBL421291 | 0.80 | MAOA (1.00) | MAOAMAOBGAAPTPRCCTSL | |
| SCHEMBL30774319 | 0.80 | GAA (1.00) | GAAPTPRCCTSLCTSSPTPN13 | |
| SCHEMBL29551149 | 0.80 | GAA (1.00) | GAAPTPRCCTSLCTSSPTPN13 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112513014-B | Light stabilizer compounds, compositions and methods | ELC 管理有限责任公司 | 2024-01-30 | — | — | CN | disclosed |
| US-11655215-B2 | Photostabilizing compounds, compositions, and methods | ELC MANAGEMENT LLC (US) | 2023-05-23 | — | — | US | disclosed |
| US-11655215-B2 | Photostabilizing compounds, compositions, and methods | ELC MANAGEMENT LLC (US) | 2023-05-23 | — | — | US | disclosed |
| US-11655215-B2 | Photostabilizing compounds, compositions, and methods | ELC MANAGEMENT LLC (US) | 2023-05-23 | — | — | US | disclosed |
| US-20210163419-A1 | PHOTOSTABILIZING COMPOUNDS, COMPOSITIONS, AND METHODS | ELC MAN LLC (US) | 2021-06-03 | — | — | US | disclosed |
| US-20210163419-A1 | PHOTOSTABILIZING COMPOUNDS, COMPOSITIONS, AND METHODS | ELC MAN LLC (US) | 2021-06-03 | — | — | US | disclosed |
| EP-3807247-A1 | PHOTOSTABILIZING COMPOUNDS, COMPOSITIONS, AND METHODS | ELC Management LLC (US) | 2021-04-21 | — | — | EP | disclosed |
| CN-112513014-A | Light stabilizer compounds, compositions and methods | ELC 管理有限责任公司 | 2021-03-16 | — | — | CN | disclosed |
| WO-2016086071-A1 | SPECTRALLY ENCODED CONSUMABLE SPECTROMETER APPARATUS AND METHODS | NUEOU, INC. (US) | 2016-06-02 | — | — | WO | disclosed |
| US-5153211-A | Enzyme inhibitors | ALCON LABORATORIES, INC. (US) | 1992-10-06 | — | — | US | disclosed |
| US-5070100-A | COMPLICATIONS OF DIABETES | ALCON LABORATORIES, INC. (US) | 1991-12-03 | — | — | US | disclosed |
| US-4864028-A | ANTIDIABETIC AGENTS | ALCON LABORATORIES, INC. (US) | 1989-09-05 | — | — | US | disclosed |
| US-4537892-A | ANTIDIABETIC AGENTS | ALCON LABORATORIES, INC. (US) | 1985-08-27 | — | — | US | disclosed |
| EP-0137333-A2 | Spiro-tricyclicaromatic succinimide derivatives as inhibitors of aldose reductase | ALCON LABORATORIES, INC. (US) | 1985-04-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210163419-A1 | PHOTOSTABILIZING COMPOUNDS, COMPOSITIONS, AND METHODS | TYR, NISCH, PPOX | MAOA 109/4885MAOB 130/4885GAA 2295/4885 |
| US-11655215-B2 | Photostabilizing compounds, compositions, and methods | TYR, NISCH, PPOX | MAOA 109/4885MAOB 130/4885GAA 2295/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.